Argon Medical Devices starts marketing CLEANERXT Rotational Thrombectomy System

NewsGuard 100/100 Score

Argon Medical Devices, Inc. announced today that the company has begun marketing the CLEANERXT Rotational Thrombectomy System as a new addition to the CLEANER family of dialysis products. With increased power and torque for cleaning wall-adherent thrombus, and the ability to be introduced through a 6 Fr sheath, CLEANERXT combines torque with trackability. Its innovative sinusoidal wire design is radiopaque and conforms to varying lumen diameters, actively cleaning wall-adherent thrombus.

Argon introduced the CLEANERXT Rotational Thrombectomy System at the 2014 Society of Interventional Radiology meeting in San Diego.  

"We continuously look at ways to improve our product offerings so that physicians can provide safe and effective therapy to their patients," stated George Leondis, President of Argon Medical Devices. "CLEANERXT provides a tremendous combination of power and minimal invasiveness. Among wall-contacting thrombectomy devices, CLEANERXT provides physicians an unmatched ability to effectively macerate wall-adherent thrombus on a 6 Fr device platform."

The CLEANERXT Rotational Thrombectomy System was designed by Rex Medical, LP for mechanical declotting of native vessel dialysis fistulae and synthetic dialysis access grafts. According to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), almost 400,000 patients undergo dialysis each year. With this product launch, patients who require thrombectomy will now have access to a more efficient and effective therapy option.

SOURCE Argon Medical Devices, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Comprehensive protein analysis reveals potential targets for treating dialysis-related amyloidosis